Nordea Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $140M | Buy |
|
|||||
|
2025
Q2 | $10.9M | Buy |
|
|||||
|
2025
Q1 | $11.4M | Sell |
|
|||||
|
2024
Q4 | $138M | Buy |
|
|||||
|
2024
Q3 | $133M | Sell |
|
|||||
|
2024
Q2 | $167M | Buy |
|
|||||
|
2024
Q1 | $139M | Buy |
|
|||||
|
2023
Q4 | $131M | Buy |
|
|||||
|
2023
Q3 | $109M | Buy |
|
|||||
|
2023
Q2 | $102M | Buy |
|
|||||
|
2023
Q1 | $84.5M | Sell |
|
|||||
|
2022
Q4 | $85.9M | Buy |
|
|||||
|
2022
Q3 | $79.6M | Buy |
|
|||||
|
2022
Q2 | $69.7M | Sell |
|
|||||
|
2022
Q1 | $69.6M | Buy |
|
|||||
|
2021
Q4 | $59.4M | Buy |
|
|||||
|
2021
Q3 | $43.7M | Buy |
|
|||||
|
2021
Q2 | $42.9M | Buy |
|
|||||
|
2021
Q1 | $41.3M | Buy |
|
|||||
|
2020
Q4 | $32.9M | Buy |
|
|||||
|
2020
Q3 | $29M | Sell |
|
|||||
|
2020
Q2 | $51.7M | Buy |
|
|||||
|
2020
Q1 | $13.9M | Sell |
|
|||||
|
2019
Q4 | $13.4M | Buy |
|
|||||
|
2019
Q3 | $9.4M | Buy |
|
|||||
|
2019
Q2 | $10.1M | Buy |
|
|||||
|
2019
Q1 | $8.64M | Buy |
|
|||||
|
2018
Q4 | $2.29M | Buy |
|
|||||
|
2018
Q3 | $2.67M | Sell |
|
|||||
|
2018
Q2 | $2.98M | Buy |
|
|||||
|
2018
Q1 | $2M | Sell |
|
|||||
|
2017
Q4 | $1.84M | Sell |
|
|||||
|
2017
Q3 | $1.92M | Buy |
|
|||||
|
2017
Q2 | $1.61M | Buy |
|
|||||
|
2017
Q1 | $1.35M | Buy |
|
|||||
|
2016
Q4 | $743K | Sell |
|
|||||
|
2016
Q3 | $891K | Buy |
|
|||||
|
2016
Q2 | $856K | Hold |
|
|||||
|
2016
Q1 | $791K | Hold |
|
|||||
|
2015
Q4 | $1.25M | Buy |
|
|||||
|
2015
Q3 | $896K | Hold |
|
|||||
|
2015
Q2 | $1.06M | Sell |
|
|||||
|
2015
Q1 | $1.04M | Hold |
|
|||||
|
2014
Q4 | $1.04M | Sell |
|
|||||
|
2014
Q3 | $1.12M | Sell |
|
|||||
|
2014
Q2 | $1.87M | Hold |
|
|||||
|
2014
Q1 | $1.39M | Buy |
|
|||||
|
2013
Q4 | $1.4M | Buy |
|
|||||
|
2013
Q3 | $1.33M | Buy |
|
|||||
|
2013
Q2 | $1.13M | Buy |
|